AstraZeneca Profit Falls on Generic Competition

Feb. 6 (Bloomberg) -- AstraZeneca said fourth-quarter profit fell as sales of its best-selling medicines and growth in emerging markets failed to compensate for increasing generic competition. Anna Edwards reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
Why the RBA Will Leave Rates Unchanged: Lakos
47:13 - Macquarie's Martin Lakos explains why he thinks the Reserve Bank of Australia will leave rates unchanged. He speaks with Bloomberg's Shery Ahn on "Trending Business." (Source: Bloomberg)
  • Over 100 Questioned in Xi’s Graft Inquiry
  • Westpac CFO Says Bank 'Strongly Capitalized' for Risks
  • Euro’s April Rally Biggest in Five Years